Active Ingredient: REPAGLINIDE
Proprietary Name: REPAGLINIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090252
Product Number: 001
Approval Date: Aug 23, 2013
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information